Intel Corporation (INTC)
Is Intel Stock a Turnaround Opportunity or a Value Trap?
Explore the exciting world of Intel (INTC 1.15%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
What Intel, Meta Platforms, and Nvidia Stock Investors Should Know About Recent Updates
In today's video, I discuss recent updates impacting Nvidia (NVDA 0.76%) and other technology companies. To learn more, check out the short video, consider subscribing, and click the special offer link below.
Intel (INTC) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Intel (INTC) stood at $23.96, denoting a -0.66% change from the preceding trading day.
Intel Introduces Innovative Edge AI Solution Suit: Stock to Gain?
INTC unveils a cutting-edge AI product suite to accelerate AI deployment at enterprises' edge infrastructure.
Intel Stock Drops as Takeover of Foundry Looks Less Likely
Nvidia CEO Jensen Huang poured cold water on the idea of a consortium led by TSMC taking over its chip-manufacturing operations.
Intel Stock Rallies on Leadership Change—Time to Buy or Wait?
Intel Corporation NASDAQ: INTC continues to defy market headwinds, extending its stock market rally. After a 7% climb in the previous session and a cumulative increase of roughly 25% since the announcement of its new Chief Executive Officer, the semiconductor giant's shares have leveled off today.
Intel: A Sum-Of-Parts Valuation Analysis Shows Significant Upside
Intel, with declining revenues, margins, and asset efficiency, faces significant challenges. Despite restructuring efforts, Intel's financial performance continues to decline, with FY24 revenues down 33% from FY21 and net income turning negative. A sum of parts of three independent units - Intel Products, Intel Foundry, and Architecture Design - points to significant shareholder value, with a potential total market cap of $393 billion.
Intel And Crispr: 2 'Bond-Like' Option Trades Yielding 13%+
Selling put options on Intel and CRISPR Therapeutics could yield high returns with only moderate risk, given their respective market conditions and potential upside. For Intel, selling $22 strike June 20th puts offers a 19.07% annualized yield, with a -19.8% breakeven, supported by strong fundamentals and a new CEO. For CRISPR, selling $30 strike July 18th puts offers a 13.51% annualized yield, with a -29% breakeven, backed by a promising biotech pipeline and recent drug approval.
Chip stocks: How to play Nvidia, Arm Holdings, Intel
This week, new Intel (INTC) CEO Lip-Bu Tan officially took the reins at the chip giant this week. But there is still a lot of uncertainty about what lies ahead for the chipmaker.
Nvidia CEO says company has not been asked to buy a stake in Intel
Nvidia CEO Jensen Huang said on Wednesday that his company has not been approached about purchasing a stake in Intel.
Why Intel Stock Is Sinking Today
Intel (INTC -6.75%) stock is seeing a big sell-off in Wednesday's trading due to chip foundry news. The semiconductor company's share price was down 7.1% as of 3 p.m.
Intel: Bring The Popcorn, This Turnaround Could Be Exciting
Intel's new CEO, Lip-Bu Tan, has a stellar track record and is expected to drive a significant turnaround, making Intel a Strong Buy. INTC's Foundry Services, if successful, could rival TSMC, potentially boosting Intel's market share and valuation significantly. Despite recent struggles, the Company's vertically integrated business model and substantial investments in R&D position it for long-term growth.
